Clinical Trial Update: A Study in Subjects With Recurrent Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in recurrent malignant glioma has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: Eisai Inc. | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2016-05-23